The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice
Julien Vollaire(Inserm), Pascale A. Cohen(Lyon 1 Université), Jean‐Luc Coll(Unknown), Lamia Bouazza(Lyon 1 Université), Aurélie Bellanger(Lyon 1 Université), Irma Machuca‐Gayet(Université Claude Bernard Lyon 1), Soumaya El Moghrabi(Physiopathologie, diagnostic et traitements des maladies musculo-squelettiques), J. Lavaud(Inserm), Véronique Josserand(Centre National de la Recherche Scientifique), Isabelle Treilleux(Centre Léon Bérard), Olivier Peyruchaud(Université Claude Bernard Lyon 1)
Cited by 32
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of mice
|Journal of Clinical Investigation|2010|318
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302